This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2024 - Rare Disease Summit
March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA

Imran Babar
Chief Business Officer at Sudo BioSciences


Imran is CBO at Sudo Biosciences and serves on the Board for Rare Genomics Institute.Previously, Imran was the CBO of Cydan, an NEA and Pfizer Ventures-backed orphan drug accelerator. He is also co-founder of several companies including Arvada. Prior to Cydan, Imran was on the venture capital team at OrbiMed Advisors and the biotechnology equity research team at Cowen. Imran is also co-founder of Rare Genomics Institute, a nonprofit dedicated to helping patients with rare diseases.Imran completed his PhD in Molecular Biology at Yale and his BA in Biology at Carleton College.

Agenda Sessions

  • Innovation station - Rapid Fire Case Studies Directly from the Thought Leaders Innovating in the Rare Disease Space

  • Brain Storming Session - Hot Topic Break Down